Table 1.
Inclusion criteria | Exclusion criteria |
Type of study | |
Randomised clinical trials (RCT), cohorts, longitudinal studies, cross-sectional studies | Reviews, letters, reports, comments, opinions, editorials, case studies and case series, conference and meeting abstracts as well as other non-peer-reviewed abstracts/articles, grey literature |
Participants | |
COPD and/or asthma–COPD overlap | Other pulmonary diseases such as asthma |
Outcomes | |
Clinical usefulness and reproducibility of FeNO alone or combined with other inflammatory biomarkers | Without any focus on FeNO |
COPD, chronic obstructive pulmonary disease; FeNO, fractional exhaled nitric oxide.